Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Once a month osteoporosis pill launched

September 21, 2005 Sales and Marketing

News

New data gives Seretide upper hand in respiratory battle

September 20, 2005 Sales and Marketing

Seretide's domination in the global respiratory market looks set to be bolstered by a new head to head study with …
News

Handing over the reins of power

September 14, 2005 Sales and Marketing

From poetry to patronage, finding a new chief executive for any pharma or biotech company can be a complicated business, …
Feature

Dealing with the generic threat

September 14, 2005 Sales and Marketing

The looming spectre of generics is one which no pharma company with successful medicines on the market can afford to …
Feature

Connecting with customers

September 13, 2005 Sales and Marketing

Great creative executions, those that have the 'wow' factor and stand out from the crowd, require long-term brand strategy and …
Feature

Exubera receives FDA vote of confidence

September 9, 2005 Research and Development, Sales and Marketing

Exubera, the first inhaled insulin treatment for diabetes, has moved a step closer to US approval following recommendation approval from …
News

Pfizer and Sanofi battle challenges on patents

September 8, 2005 Sales and Marketing

Two blockbuster drugs are facing key patent challenges on both sides of the Atlantic, with the outcome of the cases …
News

A far stricter code – but more scope for communication too

September 8, 2005 Sales and Marketing

A much tighter UK pharmaceutical industry code of practice looks set to be introduced shortly, with a broad range of …
News

Industry braced for new upheaval in primary care

September 8, 2005 Sales and Marketing NHS, PCTs, Pfizer

 Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …
News

Merck’s problems deepen as MHRA reveals investigation

September 8, 2005 Sales and Marketing

The controversy around the withdrawal of Vioxx has taken a new twist with news its manufacturer is being investigated for …
News

New RA drug from BMS gains recommendation

September 7, 2005 Sales and Marketing

A new treatment for rheumatoid arthritis from Bristol-Myers Squibb has received recommendation approval from an FDA committee, bringing it one …
News

$1 billion Cialis closing on Viagra

September 6, 2005 Sales and Marketing

Erectile dysfunction drug Cialis has achieved cumulative sales of $1 billion and is closing the gap on Pfizer's market leader …
News

All new product marketing to be pre-vetted in UK

September 2, 2005 Medical Communications, Sales and Marketing

Advertising and marketing materials for all new products are to be vetted by the UK regulator for the accuracy of …
News

Takeda’s dependence-free sleeping pill approved

September 2, 2005 Research and Development, Sales and Marketing

A new sleeping pill which patients cannot abuse or become dependent on has been approved in the US.Takeda's Rozerem (ramelteon) …
News

MHRA considers POM to P migraine drug switch

August 22, 2005 Sales and Marketing

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025